Covid-19 vaccine distribution: A roadmap for the poor countries?
Even before the official approval was given, the United States and European…
Lessons learned by Pharma during the pandemic
From cities under lockdown to the most affected areas, the coronavirus pandemic…
Vaccine development challenges: The HCV story
Hepatitis C virus causes both chronic and acute infections and a total of two…
Real-world data: how to collect it, analyse it and use it
Real world data (RWD) are information reported and collected from real-world…
ESC 2020 Digital Health Week – Part IV
As part of our coverage of the Digital Health space, the LucidQuest team has…
ESC 2020 Digital Health Week – Part III
As part of our coverage of the Digital Health space, the LucidQuest team has…
ESC 2020 Digital Health Week – Part II
As part of our coverage of the Digital Health space, the LucidQuest team has…
ESC 2020 Digital Health Week - Part I
As part of our coverage of the Digital Health space, the LucidQuest team has…
Virtual vs. In-person conferences: Which is better?
The situation What is the common factor among ASCO 2020, AACR 2020, EAN 2020,…
Virtual clinical trials – Can this be the new normal?
With the high severity and more significant contagion effect, this pandemic has…
Migraine treatments and what the future holds
Migraine remains a condition with no cure and without a fully understood…
BioPharma Corporate Venture Capital Investment Trends (2020 edition)
We recently analyzed the portfolios and activities of 22 BioPharma CVCs; you…
